Advances in Molecular Imaging Strategies for In Vivo Tracking of Immune Cells

Tracking of immune cells in vivo is a crucial tool for development and optimization of cell-based therapy. Techniques for tracking immune cells have been applied widely for understanding the intrinsic behavior of immune cells and include non-radiation-based techniques such as optical imaging and magnetic resonance imaging (MRI), radiation-based techniques such as computerized tomography (CT), and nuclear imaging including single photon emission computerized tomography (SPECT) and positron emission tomography (PET). Each modality has its own strengths and limitations. To overcome the limitations of each modality, multimodal imaging techniques involving two or more imaging modalities are actively applied. Multimodal techniques allow integration of the strengths of individual modalities. In this review, we discuss the strengths and limitations of currently available preclinical in vivo immune cell tracking techniques and summarize the value of immune cell tracking in the development and optimization of immune cell therapy for various diseases.

[1]  Erwin G. Van Meir,et al.  Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Michael Loran Dustin,et al.  T Cell Receptor Signaling Precedes Immunological Synapse Formation , 2002, Science.

[3]  Sumati Rajagopalan,et al.  Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.

[4]  A. Chawla.  Control of macrophage activation and function by PPARs. , 2010, Circulation research.

[5]  S. Jeong,et al.  Visualization of the Biological Behavior of Tumor-Associated Macrophages in Living Mice with Colon Cancer Using Multimodal Optical Reporter Gene Imaging , 2016, Neoplasia.

[6]  G. Piaggio,et al.  In Vivo Imaging of Natural Killer Cell Trafficking in Tumors , 2015, The Journal of Nuclear Medicine.

[7]  H. Kirchner,et al.  Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused into patients suffering from renal cell carcinoma. , 2004, Stem cells and development.

[8]  June-Key Chung,et al.  Molecular-Genetic Imaging Based on Reporter Gene Expression , 2008, Journal of Nuclear Medicine.

[9]  Xiaoyin Xu,et al.  Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate , 2014, BMC Biotechnology.

[10]  Baris Turkbey,et al.  Review of functional/anatomical imaging in oncology , 2012, Nuclear medicine communications.

[11]  J. Steinbach,et al.  Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[12]  Yasuyoshi Watanabe,et al.  [Molecular imaging for drug development]. , 2007, Brain and nerve = Shinkei kenkyu no shinpo.

[13]  T. Whiteside,et al.  In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma , 2006, Journal of Translational Medicine.

[14]  A. Rehemtulla,et al.  Molecular Imaging , 2009, Methods in Molecular Biology.

[15]  Marc Kachelriess,et al.  Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  A. Schmid,et al.  In Vivo Tracking of Th1 Cells by PET Reveals Quantitative and Temporal Distribution and Specific Homing in Lymphatic Tissue , 2014, Journal of Nuclear Medicine.

[17]  Peter van Gelderen,et al.  Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.

[18]  J. Chan,et al.  How B cells shape the immune response against Mycobacterium tuberculosis , 2009, European journal of immunology.

[19]  U. V. von Andrian,et al.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. , 2004, Annual review of immunology.

[20]  E. Rummeny,et al.  Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors. , 2008, Nuclear medicine and biology.

[21]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[22]  H. Daldrup-Link,et al.  Optical Imaging of Cellular Immunotherapy against Prostate Cancer , 2009, Molecular imaging.

[23]  Cristina Martelli,et al.  In vivo imaging of immune cell trafficking in cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Byeong-Cheol Ahn,et al.  Requisites for successful theranostics with radionuclide-based reporter gene imaging , 2014, Journal of drug targeting.

[25]  Jeff W M Bulte,et al.  In vivo MRI cell tracking: clinical studies. , 2009, AJR. American journal of roentgenology.

[26]  W. Oyen,et al.  Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. , 2003, Cancer research.

[27]  P. Hwu,et al.  Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer , 2008, Proceedings of the National Academy of Sciences.

[28]  Michael D. Cahalan,et al.  Two-photon tissue imaging: seeing the immune system in a fresh light , 2002, Nature Reviews Immunology.

[29]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[30]  B. Heyman,et al.  Regulation of antibody responses via antibodies, complement, and Fc receptors. , 2000, Annual review of immunology.

[31]  B. Ahn,et al.  Development of Drugs and Technology for Radiation Theragnosis , 2016 .

[32]  S. Jeong,et al.  Trafficking Macrophage Migration Using Reporter Gene Imaging with Human Sodium Iodide Symporter in Animal Models of Inflammation , 2010, The Journal of Nuclear Medicine.

[33]  C. Lau,et al.  Pathogenesis of systemic lupus erythematosus , 2003, Journal of clinical pathology.

[34]  M. Wendland,et al.  MRI of Tumor-Associated Macrophages with Clinically Applicable Iron Oxide Nanoparticles , 2011, Clinical Cancer Research.

[35]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[36]  S. Jeong,et al.  Combined Fluorescence and Magnetic Resonance Imaging of Primary Macrophage Migration to Sites of Acute Inflammation Using Near-Infrared Fluorescent Magnetic Nanoparticles , 2015, Molecular Imaging and Biology.

[37]  Christopher H Contag,et al.  Understanding immune cell trafficking patterns via in vivo bioluminescence imaging , 2002, Journal of cellular biochemistry. Supplement.

[38]  R. Jain,et al.  Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors. , 1993, Cancer research.

[39]  C. Contag,et al.  Adoptive Immunotherapy of Experimental Autoimmune Encephalomyelitis Via T Cell Delivery of the IL-12 p40 Subunit1 , 2001, The Journal of Immunology.

[40]  E. Rummeny,et al.  In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging , 2004, European Radiology.

[41]  G. Lucignani,et al.  Molecular imaging: A new way to study molecular processes in vivo , 2006, Molecular and Cellular Endocrinology.

[42]  F. Eckstein,et al.  Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages , 2014, Arthritis Research & Therapy.

[43]  P. Allen,et al.  Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.

[44]  F. Seiler,et al.  [Structure and function of immunoglobulins]. , 1982, Beitrage zu Infusionstherapie und klinische Ernahrung.

[45]  Jin Seong Lee,et al.  MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice. , 2006, Radiology.

[46]  K. Cichutek,et al.  Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective. , 2006, Journal of immunotherapy.

[47]  Mangala Srinivas,et al.  Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model , 2007, Magnetic resonance in medicine.

[48]  Sanjiv S. Gambhir,et al.  Trafficking Mesenchymal Stem Cell Engraftment and Differentiation in Tumor‐Bearing Mice by Bioluminescence Imaging , 2009, Stem cells.

[49]  A. Ribas,et al.  An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy. , 2016, Cancer research.

[50]  T. Lebien,et al.  B lymphocytes: how they develop and function. , 2008, Blood.

[51]  S. Jeong,et al.  Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodium iodide symporter and enhanced firefly luciferase genes , 2015, Scientific Reports.

[52]  L. Zitvogel,et al.  Trial watch , 2013, Oncoimmunology.

[53]  T. Gajewski,et al.  Cancer immunotherapy , 2012, Molecular oncology.

[54]  R. Welsh.  Natural killer cells and interferon. , 1984, Critical reviews in immunology.

[55]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[56]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[57]  R. Tsien,et al.  Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects , 2004, Cancer Research.

[58]  Y. Lim,et al.  Noninvasive imaging of dendritic cell migration into lymph nodes using near‐infrared fluorescent semiconductor nanocrystals , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  J. Bulte,et al.  Tracking immune cells in vivo using magnetic resonance imaging , 2013, Nature Reviews Immunology.

[60]  L. Steinman,et al.  Design of effective immunotherapy for human autoimmunity , 2005, Nature.

[61]  Hua Ai,et al.  Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner. , 2015, Biomaterials.

[62]  H. Kirchner,et al.  Monitoring of a new approach of immunotherapy with allogenic 111In-labelled NK cells in patients with renal cell carcinoma , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[63]  Thomas Beyer,et al.  To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  J. Renauld,et al.  Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. , 1999, Cytokine.

[65]  Byeong-Cheol Ahn,et al.  In Vivo Cell Tracking with Bioluminescence Imaging , 2015, Nuclear Medicine and Molecular Imaging.

[66]  M. Phelps,et al.  Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanoma-expressed self-antigen , 2008, International immunology.

[67]  M. Croft,et al.  Helper T‐Cell Subsets: Phenotype, Function and the Role of Lymphokines in Regulating their Development , 1991, Immunological reviews.

[68]  G. Sundaresan,et al.  Near-Infrared Imaging of Adoptive Immune Cell Therapy in Breast Cancer Model Using Cell Membrane Labeling , 2014, PloS one.

[69]  Christopher H Contag,et al.  Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. , 2003, Blood.

[70]  W. Moon,et al.  In vivo Tracking of Dendritic Cell using MRI Reporter Gene, Ferritin , 2015, PloS one.

[71]  Wen-chao Song,et al.  Complement and its role in innate and adaptive immune responses , 2010, Cell Research.

[72]  K. Brindle,et al.  Assessing responses to cancer therapy using molecular imaging. , 2006, Biochimica et biophysica acta.

[73]  Guy Bormans,et al.  PET Imaging of Macrophage Mannose Receptor–Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments , 2015, The Journal of Nuclear Medicine.

[74]  A. Popovtzer,et al.  Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging. , 2015, ACS nano.

[75]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[76]  A. Moretti,et al.  Evaluation of in vivo labelled dendritic cell migration in cancer patients , 2004, Journal of Translational Medicine.

[77]  M. Caligiuri,et al.  Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. , 1999, Journal of immunology.

[78]  K. Calame,et al.  Plasma cells: finding new light at the end of B cell development , 2001, Nature Immunology.

[79]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[80]  Stefano Papa,et al.  NK Cells and Cancer1 , 2007, The Journal of Immunology.

[81]  R. Blasberg,et al.  A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[82]  A. Tsourkas,et al.  In Vivo, Multimodal Imaging of B Cell Distribution and Response to Antibody Immunotherapy in Mice , 2010, PloS one.

[83]  P. Moingeon,et al.  Cancer vaccines based on dendritic cells loaded with tumor-associated antigens , 2004, Cell Biology and Toxicology.

[84]  Michael V. Green,et al.  Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. , 2002, Journal of immunological methods.

[85]  M. Smyth,et al.  Activating and inhibitory receptors of natural killer cells , 2011, Immunology and cell biology.

[86]  T. Kevin Hitchens,et al.  Tracking T-cells in vivo with a new nano-sized MRI contrast agent. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[87]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[88]  J. Chewning,et al.  Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model1 , 2009, BMC Immunology.

[89]  L. Zitvogel,et al.  Natural-killer cells and dendritic cells: "l'union fait la force". , 2005, Blood.

[90]  M. Albert,et al.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.

[91]  J. Schoenen.  “L’union fait la force” , 2013, Acta Neurologica Belgica.

[92]  H. Youn,et al.  In Vivo Non Invasive Molecular Imaging for Immune Cell Tracking in Small Animals , 2012, Immune network.

[93]  M. Rodriguez-Porcel.  In Vivo Imaging and Monitoring of Transplanted Stem Cells: Clinical Applications , 2010, Current Cardiology Reports.

[94]  X. Bosch,et al.  Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases , 2011, Pharmacological Reviews.

[95]  S. Goodman,et al.  Systemic trafficking of macrophages induced by bone cement particles in nude mice. , 2008, Biomaterials.

[96]  R. Steinman,et al.  Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. , 1999, Human immunology.

[97]  Menachem Motiei,et al.  Nanoparticles as computed tomography contrast agents: current status and future perspectives. , 2012, Nanomedicine.

[98]  G. Lucignani,et al.  Molecular imaging of cell-mediated cancer immunotherapy. , 2006, Trends in biotechnology.

[99]  N. Maitland,et al.  Macrophages in gene therapy: cellular delivery vehicles and in vivo targets , 2002, Journal of leukocyte biology.

[100]  J. Browning.  B cells move to centre stage: novel opportunities for autoimmune disease treatment , 2006, Nature Reviews Drug Discovery.

[101]  Sang-Woo Lee,et al.  Dual Reporter Gene Imaging for Tracking Macrophage Migration Using the Human Sodium Iodide Symporter and an Enhanced Firefly Luciferase in a Murine Inflammation Model , 2013, Molecular Imaging and Biology.

[102]  L. Zitvogel,et al.  Trial watch , 2013 .